World Health Organization. (2019). International Statistical Classification of Diseases and Related Health Problems, 10th Revision (ICD-10). WHO Press.
[2]
American Cancer Society. (2023). Bladder Cancer Facts and Statistics. Atlanta: American Cancer Society.
[3]
European Association of Urology. (2023). Guidelines on Non-Muscle-Invasive Bladder Cancer. Arnhem: EAU Guidelines Office.
[4]
National Comprehensive Cancer Network. (2023). NCCN Clinical Practice Guidelines in Oncology: Bladder Cancer. Version 2.2023.
[5]
Sung H, Ferlay J, Siegel RL, et al. (2021). Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 71(3), 209-249.
[6]
Babjuk M, Burger M, Compérat EM, et al. (2022). European Association of Urology Guidelines on Non-Muscle-Invasive Bladder Cancer (TaT1 and Carcinoma In Situ). European Urology, 81(1), 75-94.